Exact Sciences Corporation (EXAS) reported a net loss of 21 cents in third-quarter 2024 compared with break-even earnings in the year-ago quarter. The figure was wider than the Zacks Consensus Estimate of a loss of 20 cents per share.EXAS’ Q3 RevenuesConsolidated revenues totaled $708.7 million, up 12.8% on a reported basis and 13% on a core revenue basis. The figure missed the Zacks Consensus Estimate by 1.2%.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.Following the announcement, ...